|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
FY2020
12 months to Dec 31, 2020
|
FY2019
12 months to Dec 31, 2019
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation expense | |||||
| Accretion income recognized on loans | |||||
| Amortization of other intangibles assets | |||||
| Amortization of premium on securities, net | |||||
| Amortization of discount and origination costs on borrowings | |||||
| Stock based compensation expense | |||||
| Excess tax expense (benefit) on restricted stock vested | |||||
| FHLB stock dividends | |||||
| (Gain) loss on sale and disposal of premises and equipment | |||||
| Loss (gain) on loans | |||||
| Gain on sale of branch | |||||
| Gain on sale of trust business | |||||
| Gain on sale of securities available for sale | |||||
| Loss (gain) on sale of other real estate owned | |||||
| Impairment of other real estate | |||||
| Impairment of other assets | |||||
| Deferred tax (benefit) expense | |||||
| Provision for credit losses | |||||
| Increase in cash surrender value of BOLI | |||||
| Excess benefit claim on BOLI | |||||
| Net gain on mortgage loans held for sale | |||||
| Originations of loans held for sale | |||||
| Proceeds from sale of loans held for sale | |||||
| Net change in other assets | |||||
| Net change in other liabilities | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Proceeds from maturities, calls and paydowns, AFS | |||||
| Proceeds from sales, AFS | |||||
| Purchases, AFS | |||||
| Purchases of certificates of deposit held in other banks | |||||
| Purchases, HTM | |||||
| Proceeds from maturities of certificates of deposit held in other banks | |||||
| Proceeds from benefit claim of BOLI | |||||
| Purchase of bank owned life insurance contracts | |||||
| Purchases of FHLB stock and other restricted stock | |||||
| Proceeds from redemptions of FHLB stock and other restricted stock | |||||
| Proceeds from sale of loans | |||||
| Net loans originated held for investment | |||||
| Originations of mortgage warehouse purchase loans | |||||
| Proceeds from pay-offs of mortgage warehouse purchase loans | |||||
| Additions to premises and equipment | |||||
| Proceeds from sale of premises and equipment | |||||
| Proceeds from sale of other real estate owned | |||||
| Cash acquired in connection with acquisition | |||||
| Cash paid in connection with acquisition | |||||
| Selling costs paid in connection with branch sale | |||||
| Net cash transferred in branch sale | |||||
| Proceeds from sale of trust business | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Net (decrease) increase in demand deposits, money market and savings accounts | |||||
| Net increase (decrease) in time deposits | |||||
| Proceeds from FHLB advances | |||||
| Repayments of FHLB advances | |||||
| Proceeds from other borrowings | |||||
| Repayments of other borrowings | |||||
| Offering costs paid in connection with acquired bank | |||||
| Repurchase of common stock | |||||
| Dividends paid | |||||
| Net cash provided by (used in) financing activities | |||||
| Net change in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of period | |||||
| Cash and cash equivalents at end of period | |||||
Loading...